跳至主要内容
临床试验/NCT04965246
NCT04965246已完成不适用

Trial Assessing Light Intensity Exercise on the Health of Older Breast Cancer Survivors

Milton S. Hershey Medical Center2 个研究点 分布在 1 个国家目标入组 46 人开始时间: 2021年11月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
46
试验地点
2
主要终点
Markers of inflammation: C-reactive protein

研究概览

简要总结

The Trial Assessing Light-Intensity Exercise on the Health of Older Breast Cancer Survivors pilot randomized controlled trial aims to evaluate the efficacy of a home-based, light-intensity physical activity intervention among 56 obese, older adult breast cancer survivors, in comparison to a usual care control condition.

详细描述

The investigators will recruit 56 obese, older adult breast cancer survivors at least 1 year, and up to 10 years post-breast cancer treatment, and randomize them to either a 15 week light-intensity physical activity intervention, or usual care group.

Intervention: The participants will receive weekly support calls, and instructed to increase their light-intensity physical activity, to achieve at least 150 minutes per week. The frequency, intensity, time, and type of physical activity will be modified to maximize adherence and compliance. The support calls developed for this trial target older adults' capabilities, opportunities, and motivations for physical activity.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
65 Years 至 84 Years(Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age 65-84 years
  • 1-10 years post-breast cancer treatment
  • Body mass index ≥30
  • ≥1 drink per week over the last month
  • ≥21 on the Telephone Interview For Cognitive Status
  • ≤7 on the Alcohol Use Disorder Identification Test
  • Fluent in written and spoken English
  • Must be able to provide and understand informed consent
  • Primary physician approval

排除标准

  • Body mass index <30
  • < 21 on the Telephone Interview for Cognitive Status
  • >7 on the Alcohol Use Disorder Inventory Test
  • Other neurological or major psychiatric disorders
  • Significant heart or lung disease
  • Limited life expectancy
  • Other factors that could potentially limit ability to participate fully in the intervention
  • Self-reporting achieving over 150 minutes of moderate-to-vigorous physical activity per week.

结局指标

主要结局

Markers of inflammation: C-reactive protein

时间窗: 15 weeks

A cytokine multiplex will assess markers of inflammation, including C-reactive protein

次要结局

  • Fatigue(15 weeks)
  • Sleep Disturbance(Baseline)
  • Ability to Participate in Social Roles and Activities(15 weeks)
  • Physical Function-walk test(15 weeks)
  • Depressive Symptoms(15 weeks)
  • Physical Function-The Patient-Reported Outcomes Measurement Information System(15 weeks)
  • Pain intensity(15 weeks)
  • Anxiety Symptoms-State-Trait Anxiety Inventory(15 weeks)
  • Anxiety Symptoms-The Patient-Reported Outcomes Measurement Information System(15 weeks)
  • Pain interference(15 weeks)
  • Alcohol consumption(15 weeks)
  • Mobile Monitoring of Cognitive Change(Week 14-15)
  • The Functional Assessment of Cancer Therapy-Cognitive Function-Perceived Cognitive Impairments(15 weeks)
  • The Functional Assessment of Cancer Therapy-Cognitive Function-perceived cognitive abilities(15 weeks)
  • Markers of inflammation-Interleukin 6(15 weeks)
  • Markers of inflammation-Tumor Necrosis Factor Alpha(15 weeks)
  • The Functional Assessment of Cancer Therapy-Cognitive Function-Impact of perceived cognitive impairments on quality of life(15 weeks)
  • The Functional Assessment of Cancer Therapy-Cognitive Function-comments from others(15 weeks)
  • Sleep Disturbance-PROMIS-57(15 weeks)
  • Telephone Interview for Cognitive Status(Baseline)
  • Demographics(Baseline)
  • Alcohol consumption-daily(Week 14-15)
  • Alcohol Use Disorder(Baseline)
  • Acceptability-the proportion of older adults who agree to participate(Baseline)
  • Feasibility-the proportion of older adults who complete at least 50% of the physical activity intervention(Week 15)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Christopher Sciamanna, MD, MPH

Professor

Penn State Health Milton S Hershey Medical Center

研究点 (2)

Loading locations...

相似试验